If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNT.L Regulatory News (HNT)

  • There is currently no data for HNT

Trading Update

17 Dec 2019 07:00

RNS Number : 0634X
Huntsworth PLC
17 December 2019
 

 

17 December 2019

Trading Update

 

Huntsworth plc ("Huntsworth or the "Group"), the international healthcare and communications group, today issues a trading update for the 11 months to 30 November 2019.

 

·;

Group trading satisfactory, within market expectations

 

·;

Return to growth in Marketing

 

·;

Acquisitions successfully integrated and performing in line with expectations

 

·;

Cash flow strong and gearing expected to fall to c.1.6x at the year-end

 

 

Current Trading

The Group anticipates like-for-like revenue growth of c. 3% for the full year, with a small impact on margin as a result of investments in property and talent, and expects to report headline profit before tax within current market expectations* for the year to 31 December 2019.

As expected, the Marketing division saw an acceleration of growth over the second half of the year, although client-led project deferrals and product closures limited the level of growth to c. 3% across the half. Project wins were good, and the pipeline of opportunities is strong, especially in multi-service requirements where the additional capabilities of acquired businesses can be deployed, indicating further improvement and good prospects for 2020.

There was further good growth in the Medical division leading to c. 8% like-for-like growth for the full year. The Immersive division performed well against very strong comparatives and has secured a number of new mandates which indicate good growth prospects for 2020, although the cost of securing these mandates impacted profits.

The Communications division saw an acceleration of growth in the second half and will achieve full year revenue growth of c. 2% for the first time in several years.

 

Financial Position

The Group remains in a strong financial position, operating well within its £130m facility, and expects year end leverage to be c. 1.6x net debt to pro forma EBITDA**.

  

Outlook

The Group remains focused on delivering superior growth led by its healthcare agencies and recent acquisitions continue to complement this. Despite some currency headwinds as a result of the strengthening in sterling, management is confident about the Group's future trading and expects continued good growth across all of its businesses in 2020.

 

* Market expectations of Headline PBT range from £38.5m to £41.0m

** Pro forma EBITDA takes into account a full year's contribution from acquisitions made during 2019. Leverage is on a pre-IFRS 16 basis.

 

 

 Enquiries

 

 

Citigate Dewe Rogerson

020 7638 9571

Angharad Couch

Nick Reading

Elizabeth Kittle

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGGGGPPUPBGBQ
Date   Source Headline
8th Jul 20164:35 pmRNSPrice Monitoring Extension
6th Jul 20167:00 amRNSAdditional Listing
29th Jun 201610:34 amRNSDirector/PDMR Shareholding
28th Jun 201612:07 pmRNSSecond Price Monitoring Extn
28th Jun 201612:02 pmRNSPrice Monitoring Extension
27th Jun 201612:07 pmRNSSecond Price Monitoring Extn
27th Jun 201612:02 pmRNSPrice Monitoring Extension
24th Jun 201612:35 pmRNSNotice of Interim Results
22nd Jun 20164:49 pmRNSDirector/PDMR Shareholding
21st Jun 20162:05 pmRNSDirector/PDMR Shareholding
16th Jun 201612:22 pmRNSNotification Of Major Interest In Shares
10th Jun 201612:44 pmRNSDirector/PDMR Shareholding
3rd Jun 20162:33 pmRNSScrip Dividend Alternative
1st Jun 20161:37 pmRNSBlock listing Interim Review
26th May 20163:07 pmRNSResult of AGM
26th May 20163:03 pmRNSChange of Registered Office
19th May 20164:08 pmRNSHolding(s) in Company
16th May 20164:50 pmRNSDirectorate Change
12th May 20164:32 pmRNSHolding(s) in Company
26th Apr 201610:08 amRNSNotice of AGM
16th Mar 20162:25 pmRNSDirector/PDMR Shareholding
15th Mar 20167:00 amRNSAudited Preliminary Results
29th Feb 20163:27 pmRNSHolding(s) in Company
12th Feb 20162:42 pmRNSNotice of Preliminary Results
11th Feb 20166:00 pmRNSHolding(s) in Company
1st Feb 20162:21 pmRNSTotal Voting Rights
13th Jan 20169:42 amRNSAdditional Listing
4th Jan 20164:41 pmRNSTotal Voting Rights
1st Dec 201510:00 amRNSBlocklisting Interim Review
1st Dec 201510:00 amRNSTotal Voting Rights
24th Nov 201510:00 amRNSAppointment of new Non-Executive Director
5th Nov 201510:51 amRNSAdditional Listing
16th Oct 20157:00 amRNSAppointment of new Chief Financial Officer
8th Oct 20153:29 pmRNSScrip Dividend Alternative
6th Oct 20154:00 pmRNSDirectorate Change
28th Aug 20157:00 amRNSInterim results
3rd Aug 20151:31 pmRNSTotal Voting Rights
24th Jul 20153:52 pmRNSNotice of Interim Results
14th Jul 20153:39 pmRNSAdditional Listing
10th Jul 20154:47 pmRNSBlocklisting Interim Review
3rd Jul 20159:57 amRNSAdditional Listing
1st Jul 201510:52 amRNSTotal Voting Rights
1st Jul 201510:19 amRNSDirectorate Change
29th Jun 201510:48 amRNSAdditional Listing
16th Jun 20154:00 pmRNSResult of AGM
4th Jun 20156:30 pmRNSScrip Dividend Alternative
1st Jun 20151:38 pmRNSChange of Registered Office
18th May 20154:40 pmRNSSecond Price Monitoring Extn
18th May 20154:35 pmRNSPrice Monitoring Extension
14th May 20157:30 amRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.